ITMCTR2100004675招募中未知
The multi-center clinical study of ShenkuiTongmai Granules improving the diagnosis and treatment markers of chronic heart failure with Qi deficiency and blood stasis syndrome based on LC-MS/MS 
Jiangsu Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- All
入选标准
- •1. Voluntary participation, understanding and signing of informed consent;
- •2. Subject is between 18 and 75 years old, gender unlimited;
- •3. Subject is diagnosed of CHF for at least 3 months prior to screening according to the Chinese guidelines for the diagnosis and management of CHF published in 2018;
- •4. Subject has a documented left ventricular ejection fraction (LVEF) = 50%;
- •5. NYHA heart function classification ? ~ ? ? level (hemodynamic stability, and does not need intravenous medication).
- •6. Plasma NT-proBNP content = 450pg/ml;
- •7. Patients who have received at least 2 weeks of standardized drug therapy, and have not adjusted the dosage or given intravenous therapy;
- •Standardized drug therapy includes: diuretics, beta blockers, renin-angiotensin-aldosterone system (ACEI, ARB, and aldosterone receptor antagonists); Digitalis may be used if accompanied by atrial fibrillation.
排除标准
- •1. Heart failure caused by valvular disease, congenital heart disease, pericardium disease, arrhythmia and non-cardiogenic diseases, or failure of important organs such as liver and kidney;
- •2. Right heart failure caused by definite pulmonary or other causes, and acute heart failure, or heart failure after acute myocardial infarction;
- •3. Patients who planned to undergo revascularization therapy within 12 weeks, underwent cardiac resynchronization therapy, or planned to undergo cardiac resynchronization therapy within 12 weeks;
- •4. Patients with severe primary diseases such as liver, kidney and hematopoietic system and abnormal renal function had liver transaminase and alkaline phosphatase exceeding 1.5 times the upper limit of normal value, serum creatinine > 2mg/ dL (176.82umol/L) and serum potassium BBB>5mmol /L;Cancer patients, severe neuroendocrine system diseases and psychiatric patients;
- •5. Patients with unrepaired valvular heart disease with left ventricular outflow tract obstruction, myocarditis, large aneurysm, dissecting aneurysm, congenital heart disease, or significant hemodynamic changes;
- •6. Cardiac shock, difficult to control the degree of malignant arrhythmia, ? ? type above not in pacemaker treatment of sinus or atrioventricular block, progression of unstable angina and acute myocardial infarction;
- •7. Patients with uncontrolled hypertension with systolic blood pressure =180/mmHg and/or diastolic blood pressure =110mmHg;Systolic blood pressure <90mmHg and/or diastolic blood pressure <60mmHg;
- •8. Participated in other drug clinical researchers within 1 month;
- •9. Women who are pregnant or preparing to become pregnant and breastfeeding;
- •10. People with allergies or known allergies to therapeutic drugs;
- •11. In the investigator's judgment, the patient is unable to complete the study or to comply with the study requirements (for administrative or other reasons).
研究者
相似试验
尚未招募
不适用
A multicenter clinical study for Yiqi Tongluo Granule in the treatment of angina pectoris caused by non obstructive coronary microvascular diseaseAngina pectorisITMCTR1900002698Shanghai Municipal Hospital of Traditional Chinese Medicine
尚未招募
1 期
A randomized controlled trial of Ruanjian Qingmai Granule in the treatment of peripheral arterial diseaseperipheral arterial diseaseITMCTR2200005580shanghai TCM-Integrated Hospital
尚未招募
4 期
A multicenter, prospective cohort study of Tongqiao Biyan granule in the prevention and treatment of asthma allergic rhinitis in children based on the real medical environment and the ChiChildren's asthma allergic rhinitisITMCTR2200006864First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
招募中
1 期
Multicenter Clinical Observation of Shenfeng Zhiyang Ointment in the Treatment of Uremic Skin Pruritusremic pruritusITMCTR1900002424Department of Nephrology, the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
尚未招募
1 期
Multi center clinical study of Shenfu Xiangshao Decoction in the treatment of coronary heart disease complicated with heart failureheart failureITMCTR2000003670Shanghai Putuo District Central Hospital